Skip to content
Screener

Prestige Consumer Healthcare PBH International OTC Healthcare — Gross Profit

Other segment segments

North American OTC Healthcare
$115.94M-3.7%

Similar metrics at other companies

Superior Group of Companies, Inc. logo
SGCHealthcare Apparel — Gross Profit
$10.18M+0.5%
3D Systems logo
DDDHealthcare Solutions — Gross Profit
$22.3M+39.1%
Daktronics logo
DAKTInternational — Gross Profit
$2.84M+946%
Zoetis logo
ZTSInternational — Gross Profit
$833M+9.0%
DNOW logo
DNOWInternational — Gross Profit
$39M+255%
Fortive logo
FTVAdvanced Healthcare Solutions — Gross Profit
$197.8M+4.4%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.58B-30.3%
Enterprise value$4.55B-1.2%
P/E15×-2.4×
P/S2.3×-1.0×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:GrossProfit.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands)Three Months Ended June 30, 2026 / North American OTCHealthcareThree Months Ended June 30, 2026 / International OTCHealthcareConsolidated
Total segment revenues*$226,206$39,504$265,710
Cost of sales110,26519,257129,522
Gross profit115,94120,247136,188
Advertising and marketing28,9305,73834,668
Contribution margin$87,011$14,509$101,520
Other operating expenses49,000
Operating income$52,520
* Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment.

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's international OTC healthcare — gross profit?
Prestige Consumer Healthcare (PBH) reported international OTC healthcare — gross profit of $20.25M in Q2 2026.
How has Prestige Consumer Healthcare's international OTC healthcare — gross profit changed year-over-year?
Prestige Consumer Healthcare's international OTC healthcare — gross profit increased by 1.6% year-over-year, from $19.93M to $20.25M.
What is the long-term trend for Prestige Consumer Healthcare's international OTC healthcare — gross profit?
Over 4 years (2022 to 2026), Prestige Consumer Healthcare's international OTC healthcare — gross profit has grown at a 7.1% compound annual growth rate (CAGR), from $71.93M to $94.7M.
What does international OTC healthcare — gross profit mean?
This is the residual profit earned from international over-the-counter healthcare sales after deducting the direct costs of goods sold. It serves as a primary indicator of the segment's pricing power and manufacturing cost control. A stable or increasing gross profit margin suggests effective brand positioning and supply chain management.

Ask your AI about Prestige Consumer Healthcare's international otc healthcare — gross profit.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude